Christopher Wan

Director, Decision Science – Oncology, Radioligand Therapy (RLT) at Novartis

New York City Metropolitan Area

About

Experience

  • Novartis (East Hanover, New Jersey, United States)
    • Director, Decision Science – Oncology, Radioligand Therapy (RLT)
      Jul 2025 - Present · 1 yr

    • Director, Commercial Analytics, RLT Oncology - GEP-NET
      Jul 2024 - Jul 2025 · 1 yr 1 mo

    • Associate Director, Integrated Insights, Cardiovascular
      Jan 2023 - Jul 2024 · 1 yr 7 mos

  • Manager, Commercial Forecasting and Analytics, Ophthalmology at Regeneron Pharmaceuticals, Inc.
    Apr 2019 - Mar 2021 · 2 yrs

  • IQVIA (Greater New York City Area)
    • Sr Consultant, Real-World Insights
      Jun 2018 - Apr 2019 · 11 mos

    • Data Analytics Manager, Advanced Analytics
      Sep 2010 - Jun 2018 · 7 yrs 10 mos